17.12.2024

Teaser image to Daniel Rückert Advances Stroke Diagnosis with AI Innovation

Daniel Rückert Advances Stroke Diagnosis With AI Innovation

TUM News Article

MCML Director Daniel Rückert and his collaborators have achieved a groundbreaking milestone in medical AI. Their innovative model uses machine learning to precisely determine the timing of strokes based on CT imaging. This advancement is critical for improving stroke diagnosis and ensuring patients receive timely and effective treatment. By addressing a long-standing challenge in neurology, this research exemplifies the transformative potential of AI in healthcare.

«We believe that our model is so powerful because it not only assesses how dark the damaged region is, but also includes additional features from the scans, such as texture, and accounts for variations within the damaged areas and background.»


Daniel Rückert

MCML-Director


Subscribe to RSS News feed

Related

Link to Alena Buyx joins 3sat’s NANO Talk as new co-host

07.10.2025

Alena Buyx Joins 3sat’s NANO Talk as New Co-Host

Alena, MCML PI, co-hosts 3sat’s NANO Talk, making science engaging, from AI to nutrition, with upcoming episodes.

Link to Björn Ommer featured in WELT

26.09.2025

Björn Ommer Featured in WELT

MCML PI Björn Ommer told WELT that AI can never be entirely neutral and that human judgment remains essential.

Link to Björn Schuller featured in Macwelt article

25.09.2025

Björn Schuller Featured in Macwelt Article

MCML PI Björn Schuller discusses in Macwelt how Apple Watch monitors health, detects subtle changes, and supports early intervention.

Link to MCML PI Björn Ommer featured on ZDF NANO Talk

24.09.2025

MCML PI Björn Ommer Featured on ZDF NANO Talk

MCML PIs Björn Ommer & Alena Buyx discuss AI’s essence on ZDF NANO Talk, covering tech, ethics, and societal impact.

Link to Benjamin Lange Explores Opportunities and Risks of AI Agents

23.09.2025

Benjamin Lange Explores Opportunities and Risks of AI Agents

Benjamin Lange highlights both opportunities and ethical risks of AI agents and calls for clear rules to ensure they benefit society.

Back to Top